AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yun, A. J.
Right arrow Articles by Gerber, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yun, A. J.
Right arrow Articles by Gerber, A. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.05.0072
AJR 2006; 186:925-930
© American Roentgen Ray Society


Perspective

Integrating Systems Biology and Medical Imaging: Understanding Disease Distribution in the Lung Model

Anthony J. Yun1, Patrick Y. Lee1 and Anthony N. Gerber2

1 Department of Radiology, Stanford University, 470 University Ave., Palo Alto, CA 94301.
2 Division of Pulmonary Medicine, University of California, San Francisco, San Francisco, CA.

Received January 13, 2005; accepted after revision July 20, 2005.

Address correspondence to A. J. Yun (ayun{at}stanford.edu).

Abstract

OBJECTIVE. Many chronic diseases exhibit characteristic pulmonary distribution patterns, but the underlying biologic explanations remain elusive. On the basis of emerging evidence from systems biology, we propose that gradients of T helper immune function exist as an epiphenomenon of the hypoxic pulmonary vasoconstriction response. Regional variation of immune function may contribute to preferential distribution patterning of lung diseases.

CONCLUSION. The lungs represent but one example in which the distribution of immune function throughout the body may explain disease location. This hypothetic framework can apply to diseases outside the realm of pulmonary biology and illustrates the potential benefit of integrating advances in systems biology and medical imaging.

Keywords: adrenal gland • autonomic system • bacteria • cancer • chest • fibrosis • fungus • hypoxic • idiopathic pulmonary fibrosis • immunology • immunomodulation • lung • pulmonary sarcoidosis • sympathetic • systemic lupus erythematosus • systems biology • T helper • TH1 • TH2 • vasoconstriction • vasoconstrictor • virus • V/Q

Many chronic diseases exhibit characteristic distribution patterns. Such phenomena have undergone particular scrutiny in the lungs, where diagnosis by traditional roentgenology relies on pattern recognition. For instance, sarcoidosis shows an upper lobe predominance, whereas idiopathic pulmonary fibrosis (IPF) exhibits a lower lobe and peripheral predominance [1]. Such spatial distribution patterns aid in the differential diagnosis of radiographic findings. The association of specific diseases with particular locations has been delineated through empiric radiologic-pathologic correlation, but the biologic explanations underlying the phenomena remain elusive. However, recent evidence from molecular biology, physiology, and immunology has transformed the understanding of illnesses. An integrative or systems biology [2] approach to this newly acquired knowledge may enable radiologists to develop new models to explain the spatial variation of diseases. As an example of this emerging scientific opportunity, we propose a model in which spatial variations of autonomic and T helper (TH) balance play key roles in the distribution patterns of chronic pulmonary diseases. Although this model requires empiric validation, this paradigm could extend beyond the lungs and apply to the distribution of various diseases throughout the body.

TH1 and TH2 Immunity and the Autonomic System

Over the past two decades, the T helper subset model has emerged as a working construct to explain the dichotomous nature of the immune system [3]. CD4+ T cells can be assigned to two distinct subsets based on mutually exclusive patterns of cytokine secretion: TH1 cells and TH2 cells [4-7]. Studies in both humans and animals have shown that TH1 cells characteristically secrete interleukin-2 and interferon-{gamma}, whereas TH2 cells secrete interleukin-4 and interleukin-5 [4-6]. TH1 immunity activates macrophages and drives cell-mediated immune responses such as delayed-type hypersensitivity, and TH2 immunity drives humoral immunity through the secretion of IgG and IgE [3, 8]. Other cytokines, whether secreted by T cells or not, can also be divided into those that preferentially promote TH1 or TH2 immune functions [3]. TH1- and TH2-like polarizations of cytokine secretion patterns occur in virtually all components of the human immune system, including CD8+ T cells, B cells, dendritic cells, mast cells, macrophages, eosinophils, and natural killer cells [9].

The relationship between TH1 and TH2 immunity is viewed as adversarial in that the TH1 immune response in humans directly inhibits TH2 cytokines and vice versa [7]. Studies in murine models have shown that relative strengths of TH1 and TH2 immunity determine polarization to TH1 or TH2 bias [3], thus favoring cell-mediated or humoral immunity, respectively. Although both TH1 and TH2 functions participate in the host defense against pathogens and cancers, a TH1-biased environment is predominantly involved in defense against tumor cells and intracellular pathogens such as viruses, fungi, and mycobacteria [10]. By contrast, a TH2-biased environment is predominantly involved in defense against bacteria [10]. Given their reciprocal inhibition, the TH1 and TH2 immune responses and the human diseases associated with TH1 or TH2 polarization may mutually exclude each other [11-14].


Figure 1
View larger version (35K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 —Systems biology model explains distribution of idiopathic pulmonary fibrosis (IPF) and sarcoidosis. Hypoxic pulmonary vasoconstriction (HPV) occurs predominantly at bases and in peripheral lung (A). Because pulmonary vasoconstriction is in part mediated by sympathetic nervous system and because sympathetic nervous system causes TH2 immune bias, we propose that distribution of pulmonary vasoconstriction will lead to relative areas of TH2 versus TH1 bias, as shown in diagram B. Radiographic distributions of IPF ({circ}), which exhibits TH2 features, and of sarcoidosis (X), which exhibits TH1 features, correlate with proposed regions of relative TH2 and TH1 bias (C). Th = TH = T helper.

 
The autonomic nervous system modulates TH balance and thus reflects an important systems biology aspect of T helper cell function. Evidence indicates that the parasympathetic nervous system promotes TH1 immunity and the sympathetic nervous system promotes TH2 immunity in humans. Noradrenergic innervation is present throughout the human lymphoid system and permits direct modulation of immune function [15-17]. Sympathetic function inhibits TH1 immunity and polarizes the immune balance toward TH2 bias [18-21]. Catecholamines suppress TH1 cytokines such as interleukin-12 and interferon-{gamma} through activation of a cAMP-dependent protein kinase A pathway while stimulating TH2 cytokines [22-24]. Adrenergic promotion of the cortisol pathway in humans also buttresses a shift to TH2 bias [25-27]. Vagal activation down-regulates TH2 inflammation and generally dampens the immune response elicited by the sympathetic system [28].

Spatial Variations of Autonomic and T Helper Balance

TH2 polarization and sympathetic bias may exist in the lower and peripheral lungs because of regional variations in pulmonary vascular tone mediated by the autonomic system. A pulmonary physiologic gradient of the ventilation-perfusion (V/Q) ratio exists in humans, with a lower V/Q ratio at the caudal regions of the lung compared with cranial areas [29-31], a situation attributed to gravitational effects on blood and other factors [32]. Studies in both human and animal models have shown that in regions of lower relative ventilation in comparison with perfusion, the peripheral autonomic reflex activates the hypoxic pulmonary vasoconstriction (HPV) response to maintain optimal gas exchange by actively decreasing perfusion to regions with low V/Q ratios [33, 34]. Evaluation of spatial heterogeneity of HPV in the lungs shows higher vasoconstriction in the caudal and dorsal areas of the lung [33]. In addition, a radial ventilation gradient has been noted with lower ventilation at the periphery compared with the hilar regions [35]. These findings suggest that the perfusion to these peripheral areas may be actively limited to optimize V/Q ratios. Pulmonary arterial perfusion studies also suggest that in small-diameter peripheral arteries as compared with large central arteries, there is an increased sensitivity of vasoconstrictor response to relative hypoxia. Studies in both animal and human models suggest that this sensitivity may limit access to high capacitance pulmonary capillary bed [36-41]. Partly because of this fundamental physiology, a relatively high HPV response has been observed in the lung periphery as compared with that of central regions [36-40] (Fig. 1A).

The higher degree of vasoconstriction in the caudal and dorsal areas and periphery of the lungs may correlate with higher TH2 function in these areas. Studies in canine models have shown that modulation of sympathetic function affects the degree to which the HPV response occurs. Although the HPV response is complex and is believed to involve redox sensing, calcium and potassium influxes, and endothelial factors, there is also extensive evidence that the HPV response involves activation of the sympathetic nervous system [42, 43]. Sympathetic stimulation decreases compliance of human and animal pulmonary vasculature via {alpha}-adrenergic receptors [43, 44]. On the other hand, vagal stimulation promotes pulmonary vascular dilatation in both animals and humans [44, 45].

Airway mucosal blood flow in humans is decreased with stimulation of {alpha}-adrenergic receptors [46]. The hypoxic vasoconstriction in obstructive sleep apnea in humans is likely due to vascular remodeling in the pulmonary vasculature that is initiated by sympathetic stimulation [47]. On the other hand, vagal stimulation promotes pulmonary vascular dilatation [44, 45]. Although other mechanisms, including hypoxia and free radicals, clearly participate in the complex process of regulating vascular tone in the lungs, these mechanisms are linked with sympathetic nervous system activity [48-50]. Therefore, vertical and radial gradients of HPV are likely to be associated with increasing sympathetic function in the cranial-to-caudal and central-to-peripheral directions. Furthermore, because a higher sympathovagal ratio is associated with greater TH2 polarization, TH gradients may exist along similar axes, with relatively higher TH1 immunity situated in the upper and central lungs and relatively higher TH2 immunity localized to the lower and peripheral lungs (Fig. 1B).

Spatial Distribution of Sarcoidosis and IPF

The chronic human pulmonary diseases of sarcoidosis and IPF may follow a spatial distribution based on preexisting immune gradients in the lungs in accordance with their opposing TH balance profiles. Sarcoidosis is associated with TH1-biased environments [51-53]. Sarcoidosis appears to regress during TH2-polarizing circumstances, such as infection with HIV [54], and worsens when treated with TH1-polarizing agents such as interferon [55]. Individuals with higher genetic levels of interferon exhibit greater susceptibility to sarcoidosis [56]. On the other hand, evidence from various studies with cytokine and pathologic specimens suggests that IPF associates with TH2-polarized environments [57, 58]. Specifically, the inflammatory response in IPF appears to closely resemble a TH2-type immune response [59]. Patients with IPF manifest impaired production of interferon-{gamma}, a TH1 cytokine [60]. The potential antifibrotic properties of interferon-{gamma} served as the mechanistic basis of a recent multicenter trial evaluating its use in IPF, which revealed survival benefit in a subgroup analysis [61, 62].

The TH1/TH2 construct may help explain the preferential distribution of sarcoidosis in the upper and central lungs and IPF in the lower and peripheral lungs [63-65] (Fig. 1C). For patients with sarcoidosis, the relative dominance of TH1 immunity in the upper and central lungs may explain why the disease may start in those areas before progressing to other areas of the lung. Conversely, for patients with pulmonary fibrosis, the relative higher function of TH2 immunity in the lower and peripheral lungs may predispose to earlier involvement of those regions.

Spatial Distribution and TH2 Bias of Other Lung Diseases: The Role of Imaging

In situations in which other data paint a confusing picture, spatial distribution data based on medical imaging may clarify the biologic basis of a disease. For example, diseases such as systemic lupus erythematosus (SLE), chronic eosinophilic pneumonia, and pneumoconioses appear to show both TH1 and TH2 immune dysfunction in both human and murine models [66, 67]. Although the complex nature of the immune dysfunction in these diseases is acknowledged, the peculiar spatial distribution pattern of each disease based on imaging may help biologists define whether a disease is facilitated by a TH1- or TH2-dominant host environment. As might be expected in a condition manifesting autoantibodies [68, 69], a dysfunction of humoral immunity, SLE-related interstitial lung disease in humans generally involves the lower and peripheral lungs [1], suggesting a preferred distribution in TH2 environments [58, 70-74]. Scleroderma, another human collagen vascular disease associated with lower lobe and peripheral lung fibrosis, presents with increased skin expression of interleukin-4 [73], a TH2 cytokine. As might be expected from a condition manifesting abnormal IgE regulation, a TH2-mediated function, chronic eosinophilic pneumonia generally localizes to the peripheral lung [73, 75]. Although substantial evidence indicates that pneumoconioses are TH1-mediated diseases [76-78], some controversy still remains. In our proposed model, the upper lobe predominance of these conditions would further weigh the evidence toward these conditions favoring TH1-dominant environments [79, 80].

Although immune gradients based on sympathetic activation may be a contributing factor to the macrodistribution pattern of pulmonary disease, other factors almost certainly play independent roles. Regional variations in lung structure exist because of the underlying asymmetry of the bronchial tree. Airflow, lymphatic drainage, and penetration of septa do not distribute uniformly across the lung. Acute conditions such as infection may localize on the basis of oxygenation preferences of the pathogen, route of infection, bronchial anatomy, and comorbid pulmonary disorders. Properties of the particle may influence distribution of pulmonary disease related to environmental exposures [81]. The possibility remains that more granular microgradients between the bronchial mucosa and the pulmonary interstitium or vessels may override lungwide gradients. Underlying global TH balance may vary with age or with comorbid conditions [82]. In all cases, chronicity may enable more evanescent processes to resolve and enable immunologic forces to exert a greater degree of influence as to localization. Furthermore, some diseases may manifest a mixture of TH1 and TH2 features as part of their pathogenesis; and in other cases, the disease itself may exhibit significant mechanistic heterogeneity. Collectively, these factors introduce layers of noise such that empiric manifestations are likely to exhibit considerable variation. Thus, in diseases such as sarcoidosis and IPF, in which the immunologic evidence points more clearly toward either a TH1 or a TH2 bias, the distribution within the lungs will likely prove more definitive. Other pulmonary diseases that are more heterogeneous in terms of their immunologic profile may also exhibit a similar heterogeneity in their distribution.

Finally, some disease distributions may be explained simply by the heterogeneity of the architecture of the lung. The stasis of the lymph system in the apical portion of the lung may explain the predilection of tuberculosis for this region. That the apex of the lung also contains the largest alveoli that have the greatest tensile stress may explain the predilection for apical bullae formation in patients with Marfan syndrome [83, 84]. A more comprehensive understanding of the mechanistic basis of more pleiotropic diseases will require better integration of immunologic, radiologic, and pathologic findings.

Future Directions

Our proposed framework requires further empiric validation. Autonomic innervation is present throughout the lungs, and its functional anatomy could be further delineated with iodine-123-metaiodobenzylguanidine SPECT (MIBG SPECT), which identifies sympathetic innervation. Whether spatial variation of autonomic function generates gradients in pulmonary immune function remains to be investigated. As first shown in rodent models, the anatomic basis for autonomic modulation of TH balance in the lung [85] is supported by the recent discovery that the autonomic system directly and diffusely innervates bronchus-related lymphoid tissue, as it does lymphoid tissue throughout the body [15, 16, 86]. Spatial variation of TH balance could be confirmed with region-specific cytokine measurements or mRNA (messenger RNA) array experiments using cells from different parts of the lung to detect gene expression evidence of functional TH biases. Our model would receive further validation from the observation of a therapeutic response. We would expect corresponding shifts in pulmonary distribution patterns in conjunction with response. Once one confirms the robustness of the relationship between witnessed imaging and clinical presentations, monitoring such distribution pattern shifts may serve as an effective noninvasive method of tracking response to treatment. In addition, treatments with particular target specificities could be isolated and developed by observing their ability to alter or produce particular patterns of distribution.

Opportunities exist to extend this framework outside the pulmonary space. Many diseases exhibit eccentric distribution patterns in the body without satisfactory explanation. For instance, the adrenal gland is commonly involved with fungal, mycobacterial, and tumoral entities, which generally prefer TH2-biased environments, but not bacteria, which prefer TH1-biased environments. These propensities may represent epiphenomena related to adrenal production of steroids and catecholamines causing TH2 polarization. With access to vast amounts of in vivo empiric data, radiologists are in a unique position to observe many other repeating distribution patterns of disease. Using models constructed via a systems biology approach may benefit radiologists in how they think and practice.

Conclusions

These examples illustrate the potential role that imaging can play in the emerging field of systems biology. T helper immunology is an exciting systems-oriented field with enormous potential to elucidate the pathogenesis of diseases, but the early controversy and conflicting data are indicative of a paradigm at its embryonic stage. Our framework suggests that integration of medical imaging data into the paradigms of systems biology may play a critical role in advancing many areas of research, even in basic core science disciplines such as molecular biology and immunology. The tools enabling such integration include not only cutting-edge developments of molecular imaging techniques but also intelligent mining of the ongoing body of data collected through conventional imaging techniques.

Validation of our paradigm may prove useful for both systems biologists and medical imagers. Many eccentric distributions of chronic diseases as observed by medical imagers remain unexplained. Similarly, a mass of conflicting data regarding the TH immunity profiles of many diseases confounds biologists. Our model may play clarifying roles in both domains of scientific inquiry. We believe that medical imaging is positioned to become a substantial beneficiary of, and a contributor to, the emerging field of systems biology. We hope that the hypothetic framework presented in this article spurs discussion among radiologists and encourages greater adoption of a systems-oriented perspective that many believe will help change the way we think about diseases, their diagnosis, and their treatment.

References

  1. Muller NL, Fraser RS, Colman NC, Pare PD. Radiologic diagnosis of diseases of the chest. Philadelphia, PA: Saunders,2001
  2. Kitano H. Systems biology: a brief overview. Science 2002; 295:1662 -1664[Abstract/Free Full Text]
  3. Gor DO, Rose NR, Greenspan NS. TH1-TH2: a procrustean paradigm. Nat Immunol 2003;4 : 503-505[CrossRef][Medline]
  4. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol1986; 136:2348 -2357[Abstract]
  5. Parronchi P, Macchia D, Piccinni MP, et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci U S A 1991; 88:4538 -4542[Abstract/Free Full Text]
  6. Del Prete GF, De Carli M, Mastromauro C, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991;88 : 346-350[Medline]
  7. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1986;383 : 787-793
  8. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 1987; 138:3688 -3694[Abstract]
  9. Mosmann T. Complexity or coherence? Cytokine secretion by B cells. Nat Immunol 2000;1 : 465-466[CrossRef][Medline]
  10. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996;9 : 532-562[Abstract]
  11. Shirakawa T, Enormoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275:77 -79[Abstract/Free Full Text]
  12. Prescott SL, Sly P, Holt P. Raised serum IgE associated with reduced responsiveness to DPT vaccination during infancy. (letter) Lancet 1998; 351:1489[CrossRef][Medline]
  13. Oro AS, Guarino TJ, Driver R, Steinman L, Umetsu DT. Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol 1996; 97:1402 -1408[CrossRef][Medline]
  14. Rudwaleit M, Andermann B, Alten R, et al. Atopic disorders in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 2002; 61:968 -974[Abstract/Free Full Text]
  15. Weihe E, Nohr D, Michel S, et al. Molecular anatomy of the neuro-immune connection. Int J Neurosci1991; 59:1 -23[Medline]
  16. Felten SY, Felten DL, Bellinger DL, et al. Noradrenergic sympathetic innervation of lymphoid organs. Prog Allergy 1988; 43:14 -36[Medline]
  17. Ernst PB, Song F, Klimpel GR, et al. Regulation of the mucosal immune response. Am J Trop Med Hyg 1999;60 [4 suppl]: 2-9[Abstract]
  18. Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians 1996; 108:374 -381[Medline]
  19. Panina-Bordignon P, Mazzeo D, Lucia PD, et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 1997;100 : 1513-1519[Medline]
  20. Suberville S, Bellocq A, Fouqueray B, et al. Regulation of interleukin-10 production by beta-adrenergic agonists. Eur J Immunol 1996; 26:2601 -2605[Medline]
  21. van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest1996; 97:713 -719[Medline]
  22. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve: an integrative interface between two supersystems—the brain and the immune system. Pharmacol Res 2000;52 : 595-638
  23. Lorton D, Lubahn C, Bellinger DL. Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases. Curr Drug Targets Inflamm Allergy 2003; 2:1 -30[Medline]
  24. Leussink VI, Jung S, Merschdorf U, Toyka KV, Gold R. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Arch Neurol2001; 58:91 -97[Abstract/Free Full Text]
  25. Hassig A, Kremer H, Liang WX, Stampfli K. The role of the Th-1 to Th-2 shift of the cytokine profiles of CD4 helper cells in the pathogenesis of autoimmune and hypercatabolic diseases. Med Hypotheses1998; 51:59 -63[CrossRef][Medline]
  26. Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002; 966:290 -303[Medline]
  27. Tracey KJ. The inflammatory reflex. Nature2002; 420:853 -859[CrossRef][Medline]
  28. Mure M, Domino KB, Lindahl SG, Hlastala MP, Altemeier WA, Glenny RW. Regional ventilation-perfusion distribution is more uniform in the prone position. J Appl Physiol 2000;88 : 1076-1083[Abstract/Free Full Text]
  29. Kreck TC, Krueger MA, Altemeier WA, et al. Determination of regional ventilation and perfusion in the lung using xenon and computed tomography. J Appl Physiol 2001;91 : 1741-1749[Abstract/Free Full Text]
  30. Musch G, Layfield JD, Harris RS, et al. Topographical distribution of pulmonary perfusion and ventilation, assessed by PET in supine and prone humans. J Appl Physiol 2002;93 : 1841-1851[Abstract/Free Full Text]
  31. Glenny RW, Bernard S, Robertson HT, Hlastala MP. Gravity is an important but secondary determinant of regional pulmonary blood flow in upright primates. J Appl Physiol 1999;86 : 623-632[Abstract/Free Full Text]
  32. Hlastala MP, Lamm WJ, Karp A, Polissar NL, Starr IR, Glenny RW. Spatial distribution of hypoxic pulmonary vasoconstriction in the supine pig. J Appl Physiol 2004;9 : 1589-1599
  33. Kuriyama T, Latham LP, Horwitz LD, Reeves JT, Wagner WW Jr. Role of collateral ventilation in ventilation-perfusion balance. J Appl Physiol 1984; 56:1500 -1506[Abstract/Free Full Text]
  34. Robertson HT, Glenny RW, Stanford D, McInnes LM, Luchtel DL, Covert D. High-resolution maps of regional ventilation utilizing inhaled fluorescent microspheres. J Appl Physiol 1997;82 : 943-953[Abstract/Free Full Text]
  35. Liu Q, Sham JS, Shimoda LA, Sylvester JT. Hypoxic constriction of porcine distal pulmonary arteries: endothelium and endothelin dependence. Am J Physiol Lung Cell Mol Physiol 2001;280 : L856-L865[Abstract/Free Full Text]
  36. Herold CJ, Wetzel RC, Robotham JL, Herold SM, Zerhouni EA. Acute effects of increased intravascular volume and hypoxia on the pulmonary circulation: assessment with high-resolution CT. Radiology 1992;183 : 655-662[Abstract/Free Full Text]
  37. Al-Tinawi A, Krenz GS, Rickaby DA, Linehan JH, Dawson CA. Influence of hypoxia and serotonin on small pulmonary vessels. J Appl Physiol 1994; 6:56 -64
  38. Shirai, M, Sada K, Ninomiya I. Effects of regional alveolar hypoxia and hypercapnia on small pulmonary vessels in cats. J Appl Physiol 1986; 1:440 -448
  39. Madden, JA, Dawson CA, Harder DR. Hypoxia-induced activation in small isolated pulmonary arteries from the cat. J Appl Physiol 1985; 59:113 -118[Abstract/Free Full Text]
  40. Presson RG Jr, Audi SH, Hanger CC, et al. Anatomic distribution of pulmonary vascular compliance. J Appl Physiol1998; 84:303 -310[Abstract/Free Full Text]
  41. Brimioulle S, Vachiery JL, Brichant JF, Delcroix M, Lejeune P, Naeije R. Sympathetic modulation of hypoxic pulmonary vasoconstriction in intact dogs. Cardiovasc Res 1997;34 : 384-392[Abstract/Free Full Text]
  42. Salvi SS. Alpha1-adrenergic hypothesis for pulmonary hypertension. Chest 1999; 115:1708 -1719[Abstract/Free Full Text]
  43. Ingram RH, Szidon JP, Skalak R, Fishman AP. Effects of sympathetic nerve stimulation on the pulmonary arterial tree of the isolated lobe perfused in situ. Circ Res 1968;22 : 801-815[Abstract/Free Full Text]
  44. Wilson LB, Levitzky MG. Chemoreflex blunting of hypoxic pulmonary vasoconstriction is vagally mediated. J Appl Physiol1989; 66:782 -791[Abstract/Free Full Text]
  45. Nandiwada PA, Hyman AL, Kadowitz PJ. Pulmonary vasodilator responses to vagal stimulation and acetylcholine in the cat. Circ Res 1983; 53:86 -95[Abstract/Free Full Text]
  46. Brieva J, Wanner A. Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects. J Appl Physiol 2001; 90:665 -669[Abstract/Free Full Text]
  47. Shirai M. Vasomotor control of the pulmonary circulation [in Japanese]. Nippon Yakurigaku Zasshi 1999;113 : 235-248[Medline]
  48. Cutler MJ, Swift NM, Keller DM, Wasmund WL, Burk JR, Smith ML. Periods of intermittent hypoxic apnea can alter chemoreflex control of sympathetic nerve activity in humans. Am J Physiol Heart Circ Physiol 2004; 287:H2054 -H2060[Abstract/Free Full Text]
  49. Lassegue B, Griendling KK. Reactive oxygen species in hypertension: an update. Am J Hypertens 2004;17 : 852-860[CrossRef][Medline]
  50. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol2004; 287:H695 -H703[Abstract/Free Full Text]
  51. Larousserie F, Pflanz S, Coulomb-L'Hermine A, Brousse N, Kastelein R, Devergne O. Expression of IL-27 in human Th1-associated granulomatous diseases. J Pathol 2004;202 : 164-171[CrossRef][Medline]
  52. Katchar K, Eklund A, Grunewald J. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med 2003; 254:564 -571[CrossRef][Medline]
  53. Moller DR. Treatment of sarcoidosis: from a basic science point of view. J Intern Med 2003;253 : 31-40[CrossRef][Medline]
  54. Foulon G, Wislez M, Naccache JM, et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38:418 -425[CrossRef][Medline]
  55. Salvio A, Mormile M, Giannattasio F, et al. Pulmonary sarcoidosis during interferon therapy: a rare or underestimated event? Ann Ital Med Int 2004; 19:58 -62[Medline]
  56. Akahoshi M, Ishihara M, Remus N, et al. Association between IFNA genotype and the risk of sarcoidosis. Hum Genet2004; 114:503 -509[CrossRef][Medline]
  57. Westermann W, Schobl R, Rieber EP, Frank KH. Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat. Int J Radiat Biol 1999;75 : 629-638[CrossRef][Medline]
  58. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 2001;7 : 255-261[CrossRef][Medline]
  59. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345 : 517-525[Free Full Text]
  60. Prior C, Haslam PL. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases. Clin Exp Immunol 1992; 88:280 -287[Medline]
  61. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75:163 -189[Abstract/Free Full Text]
  62. Raghu G, Brown KK, Bradford WZ, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350 : 125-133[Abstract/Free Full Text]
  63. Fraser RG, Pare JAP, eds. Diagnosis of diseases of the chest, 3rd ed. Philadelphia, PA: Saunders,1991
  64. Copley SJ, Wells AU, Sivakumaran P, et al. Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT features. Radiology 2003;229 : 731-736[Abstract/Free Full Text]
  65. Padley SP, Padhani AR, Nicholson A, Hansell DM. Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT. Clin Radiol 1996; 51:807 -810[CrossRef][Medline]
  66. Nakajima A, Hirose S, Yagita H, Okumura K. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J Immunol 1997; 158:1466 -1472[Abstract]
  67. Schorlemmer HU, Dickneite G, Kanzy EJ, Enssle KH. Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R). Inflamm Res 1995;44 [suppl 2]:S194 -S196
  68. Theofilopoulos AN, Koundouris S, Kono DH, Lawson BR. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res 2001;3 : 136-141[CrossRef][Medline]
  69. Santiago ML, Fossati L, Kacquet C, Muller W, Izui S, Reininger L. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 1997;185 : 65-70[Abstract/Free Full Text]
  70. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003;56 : 481-490[Abstract/Free Full Text]
  71. Singh RR. IL-4 and many roads to lupuslike autoimmunity. Clin Immunol 2003;108 : 73-79[CrossRef][Medline]
  72. Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radio-Graphics 2002;22 [spec no]:S151 -S165[Abstract/Free Full Text]
  73. Salmon-Ehr V, Serpier H, Nawrocki B, et al. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures: potential role in fibrosis. Arch Dermatol1996; 132:802 -806[Abstract/Free Full Text]
  74. Katoh S, Fukushima K, Matsumoto N, et al. Accumulation of CCR4-expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy 2003; 58:518 -523[CrossRef][Medline]
  75. Katoh S, Matsumoto N, Matsumoto K, Fukushima K, Matsukura S. Elevated interleukin-18 levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy2004; 59:850 -856[CrossRef][Medline]
  76. Garn H, Friedetzky A, Davis GS, Hemenway DR, Gemsa D. T-lymphocyte activation in the enlarged thoracic lymph nodes of rats with silicosis. Am J Respir Cell Mol Biol 1997;16 : 309-316[Abstract]
  77. Garn H, Friedetzky A, Kirchner A, Jager R, Gemsa D. Experimental silicosis: a shift to a preferential IFN-gamma-based Th1 response in thoracic lymph nodes. Am J Physiol Lung Cell Mol Physiol2000; 278:L1221 -L1230[Abstract/Free Full Text]
  78. Davis GS, Pfeiffer LM, Hemenway DR. Expansion of interferon-{gamma}-producing lung lymphocytes in mouse silicosis. Am J Respir Cell Mol Biol 1999;20 : 813-824[Abstract/Free Full Text]
  79. Akira M. High-resolution CT in the evaluation of occupational and environmental disease. Radiol Clin North Am2002; 40:43 -59[CrossRef][Medline]
  80. Tinkle SS, Schwitters PW, Newman LS. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease. Environ Health Perspect 1996;104 [suppl 5]:969 -971
  81. Kamp DW, Weitzman SA. The molecular basis of asbestos induced lung injury. Thorax 1999;54 : 638-652[Free Full Text]
  82. Yun AJ, Lee PY, Bazar KA. Temporal variation of autonomic balance and diseases during circadian, seasonal, reproductive, and lifespan cycles. Med Hypotheses 2004;63 : 155-162[CrossRef][Medline]
  83. Gurney J. Cross-sectional physiology of the lung. Radiology 1991;178 : 1-10[Abstract/Free Full Text]
  84. Gurney JW, Schroeder BA. Upper lobe lung disease: physiologic correlates. Radiology 1988;167 : 359-366[Abstract/Free Full Text]
  85. Artico M, Bosco S, Bronzetti E, et al. Peribronchial innervation of the rat lung. Int J Mol Med 2004;14 : 615-620[Medline]
  86. Golder M, Burleigh DE, Belai A, et al. Smooth muscle cholinergic denervation hypersensitivity in diverticular disease. Lancet 2003; 361:1945 -1951[CrossRef][Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yun, A. J.
Right arrow Articles by Gerber, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yun, A. J.
Right arrow Articles by Gerber, A. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS